abstract |
There is disclosed a pharmaceutical agent containing a HER2 inhibitor and a hormonal therapeutic agent or anti-cancer agent in combination. Further, there is disclosed a pharmaceutical agent containing (1) a HER2 inhibitor with a pyrrolopyrimidine skeleton or pyrazolopyrimidine skeleton, and (2) a hormonal, therapeutic or anti-cancer agent in combination. |